Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.48 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.48 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.41 |
| ▸ | MEN1 | O00255 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL198065 | 0.76 | MAPT (0.61) | KDM4EMAPTHSD17B10HIF1ATXNRD1 | |
| SCHEMBL2832866 | 0.75 | MAPT (0.36) | KDM4EMAPTHSD17B10HIF1ATXNRD1 | |
| SCHEMBL1821199 | 0.73 | MAPT (0.57) | KDM4EMAPTHSD17B10HIF1ATXNRD1 | |
| SCHEMBL432155 | 0.73 | MAPT (0.57) | KDM4EMAPTHSD17B10HIF1ATXNRD1 | |
| SCHEMBL3424124 | 0.73 | KDM4E (0.57) | KDM4EMAPTHSD17B10HIF1ATXNRD1 | |
| SCHEMBL3632810 | 0.73 | MAPT (0.57) | KDM4EMAPTHSD17B10HIF1ATXNRD1 | |
| SCHEMBL1172929 | 0.73 | MAPT (0.57) | KDM4EMAPTHSD17B10HIF1ATXNRD1 | |
| SCHEMBL762283 | 0.73 | MAPT (0.57) | KDM4EMAPTHSD17B10HIF1ATXNRD1 | |
| SCHEMBL396206 | 0.73 | MAPT (1.00) | KDM4EMAPTHSD17B10HIF1ATXNRD1 | |
| SCHEMBL13836503 | 0.73 | MAPT (0.57) | KDM4EMAPTHSD17B10HIF1ATXNRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118019360-A | Organic compound, electro-optical device, electronic apparatus, and electronic apparatus | 三星显示有限公司 | 2024-05-10 | — | — | CN | disclosed |
| US-11667650-B2 | Thieno-indeno-monomers and polymers | CLAP CO., LTD. (KR) | 2023-06-06 | — | — | US | disclosed |
| US-20220041617-A1 | THIENO-INDENO-MONOMERS AND POLYMERS | BASF SE (DE) | 2022-02-10 | — | — | US | disclosed |
| US-10388881-B2 | Sorting of carbon nanotubes | BASF SE (DE) | 2019-08-20 | — | — | US | disclosed |
| US-20170229657-A1 | SORTING OF CARBON NANOTUBES | CLAP CO., LTD. (KR) | 2017-08-10 | — | — | US | disclosed |
| US-7632851-B2 | Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers | NOVARTIS AG (CH) | 2009-12-15 | — | — | US | disclosed |
| EP-1613610-B1 | BENZO 1,2,5 OXADIAZOLES AND BENZO 1,2,5 THIADIAZOLES USEFUL AS HISTOPATHOLOGICAL STAINING AGENTS, IMAGING AGENTS AND BIOMARKERS | NOVARTIS AG (CH) | 2009-07-01 | — | — | EP | disclosed |
| US-7405299-B2 | Compounds as pharmaceutical agents | ELI LILLY AND COMPANY (US) | 2008-07-29 | — | — | US | disclosed |
| US-20060093551-A1 | Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers | NOVARTIS AG (CH) | 2006-05-04 | — | — | US | disclosed |
| US-20060058295-A1 | Novel compounds as pharmaceutical agents | ELI LILLY AND COMPANY (US) | 2006-03-16 | — | — | US | disclosed |
| EP-1613610-A1 | BENZO 1,2,5 OXADIAZOLES AND BENZO 1,2,5 THIADIAZOLES USEFUL AS HISTOPATHOLOGICAL STAINING AGENTS, IMAGING AGENTS AND BIOMARKERS | Novartis AG (CH) | 2006-01-11 | — | — | EP | disclosed |
| EP-1567527-A1 | CONDENSED PYRAZOLO DERIVATIVES | ELI LILLY AND COMPANY (US) | 2005-08-31 | — | — | EP | disclosed |
| WO-2004087684-A1 | BENZO[1,2,5]OXADIAZOLES AND BENZO [1,2,5]THIADIAZOLES USEFUL AS HISTOPATHOLOGICAL STAINING AGENTS, IMAGING AGENTS AND BIOMARKERS | NOVARTIS AG (CH) | 2004-10-14 | — | — | WO | disclosed |
| WO-2004050659-A1 | NOVEL COMPOUNDS AS PHARMACEUTICAL AGENTS | ELI LILLY AND COMPANY (US) | 2004-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058295-A1 | Novel compounds as pharmaceutical agents | TGFB1, TGFB2, TGFBR1 | KDM4E 4107/4885MAPT 1061/4885HSD17B10 3162/4885 |
| US-11667650-B2 | Thieno-indeno-monomers and polymers | RPS21, OXER1, OXSR1 | KDM4E 4685/4885MAPT 3081/4885HSD17B10 1760/4885 |
| US-20220041617-A1 | THIENO-INDENO-MONOMERS AND POLYMERS | RPS21, OXER1, OXSR1 | KDM4E 4685/4885MAPT 3081/4885HSD17B10 1760/4885 |
| US-20060093551-A1 | Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers | H1-3, MKI67, H1-5 | KDM4E 3716/4885MAPT 2136/4885HSD17B10 1344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.